Establishment Labs Holdings Inc Total Assets
Establishment Labs Holdings Inc total assets. Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) holds total assets worth $351.93 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Establishment Labs Holdings Inc (ESTA) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Establishment Labs Holdings Inc (2016–2025)
Total assets of Establishment Labs Holdings Inc from 2016 to 2025. This chart illustrates how Establishment Labs Holdings Inc's total assets have evolved over time, based on quarterly financial data. See current stock price of Establishment Labs Holdings Inc for real-time trading data and today's change.
Establishment Labs Holdings Inc - Asset Composition Analysis
Establishment Labs Holdings Inc Total Assets Breakdown (December 2025)
Establishment Labs Holdings Inc total assets breakdown as of December 2025. Establishment Labs Holdings Inc's total assets of $351.93 Million consist of 70.0% current assets and 30.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 21.2% |
| Accounts Receivable | $77.50 Million | 21.7% |
| Inventory | $85.61 Million | 24.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $9.94 Million | 2.8% |
| Goodwill | $1.21 Million | 0.3% |
Asset Composition Trend (2016–2025)
This chart illustrates how Establishment Labs Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Establishment Labs Holdings Inc (ESTA) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Establishment Labs Holdings Inc's current assets represent 70.0% of total assets in 2025, an increase from 42.4% in 2016.
- Cash Position: Cash and equivalents constituted 21.2% of total assets in 2025, up from 1.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 7.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 24.0% of total assets.
Establishment Labs Holdings Inc Competitors by Total Assets
Key competitors of Establishment Labs Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Establishment Labs Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.84 | 2.84 | 4.10 |
| Quick Ratio | 2.52 | 1.67 | 3.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $183.17 Million | $148.43 Million | $94.25 Million |
Establishment Labs Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Establishment Labs Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 102.92 |
| Latest Market Cap to Assets Ratio | 5.21 |
| Asset Growth Rate (YoY) | 3.0% |
| Total Assets | $357.17 Million |
| Market Capitalization | $1.86 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Establishment Labs Holdings Inc's assets at a significant premium (5.21x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Establishment Labs Holdings Inc's assets grew by 3.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Establishment Labs Holdings Inc (2016–2025)
The table below shows the annual total assets of Establishment Labs Holdings Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $357.17 Million | +2.98% |
| 2024-12-31 | $346.83 Million | +29.11% |
| 2023-12-31 | $268.64 Million | +27.28% |
| 2022-12-31 | $211.06 Million | +51.27% |
| 2021-12-31 | $139.53 Million | -10.78% |
| 2020-12-31 | $156.39 Million | +34.20% |
| 2019-12-31 | $116.53 Million | -0.04% |
| 2018-12-31 | $116.57 Million | +104.17% |
| 2017-12-31 | $57.09 Million | +93.14% |
| 2016-12-31 | $29.56 Million | -- |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more